C
About
CDR3 performs multi-layered, high-resolution analysis of the T-cell receptor (TCR) repertoire. This enables the discovery of new insights from the immunological repertoire, particularly for therapeutic development and understanding immune responses.
Technology stack
detected 2026-05-24Est. monthly stack spend~$170/mo
EmailSelf-hosted
Hosting
Google Cloud
Stack
jQuery
Wix
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does CDR3 do?
CDR3 performs multi-layered, high-resolution analysis of the T-cell receptor (TCR) repertoire. This enables the discovery of new insights from the immunological repertoire, particularly for therapeutic development and understanding immune responses.
How much funding has CDR3 raised?
CDR3 has raised a total of $1M in funding. The most recent round on record is Seed.
When was CDR3 founded?
CDR3 was founded in 2018.
What industry does CDR3 operate in?
CDR3 operates in Healthcare, Immunology, Genomics, Computational Biology, Biotech, HealthTech.
What is CDR3's current status?
CDR3's current operating status is: Inactive.